Falciparum Malaria Clinical Trials
2 recruiting trials for Falciparum Malaria. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Falciparum Malaria clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 1 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Zydus Lifesciences Limited (1), Centro de Investigacao em Saude de Manhica (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is ZY19489 + Ferroquine (FQ) (drug, 1 trial), followed by Placebo, LDH-based malaria rapid diagnostic test.
Track Falciparum Malaria trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the...
Malaria is caused by protozoan parasites of the genus Plasmodium and it is the most important parasitic disease in terms of mortality and morbidity. Estimates of 247 million...
Malaria Molecular Surveillance in Mozambique (Phase 2)
Mozambique is among the ten countries with the highest burden of malaria worldwide, with an estimated 10.3 million cases in 2021. Malaria transmission is highly heterogeneous...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Falciparum Malaria, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Falciparum Malaria, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Falciparum Malaria, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.